American Journal of Clinical Research and Reviews


A Systemic Review on the Pharmacognosy, Phytochemistry, Pharmacological and Clinical aspects of Edible stemmed vine, Cissus quadrangularis L

Review Article of American Journal of Clinical Research and Reviews A Systemic Review on the Pharmacognosy, Phytochemistry, Pharmacological and Clinical aspects of Edible stemmed vine, Cissus quadrangularis L Anoop Austin Head - Research and Development Center, Cholayil Private Limited, # 31-A/24, 4th Cross Main road, SIDCO Industrial Estate (North Phase), Aavin Dairy road, Ambattur, Chennai - 600 098, Tamilnadu, India. Cissus quadrangularis Linn. belonging to the family Vitaceae is a common perennial climber, which is distributed throughout India. This square stemmed vine is widely used in traditional systems of medicines and parts like stem, roots and shoots are the most important parts, which are used medicinally. The article reveals a wide number of phytochemical constituents that had been isolated from the plant, which plays major role including gallic acid derivatives, steroids, iridoids, flavonoids, stilbenes and triterpenes, which possesses activities like anti inflammatory, anti tumor, gastro protective, antioxidant, antimicrobial and various other important medicinal properties. Many extensive research works had been done to prove its biological activities and pharmacology of its extracts. The current review deals with the enormous amount of updated information of scientific research and reports available in different aspects of this plant involving phytochemical, pharmacology, toxicological and clinical works. This review also includes reports on pharmacognosy, variants and traditional medicinal uses of the plant. Keywords:  Cissus quadrangularis; Vitis quadrangularis; Vitaceae; Bone Fracture; Edible stemmed vine ...

Clinical and Histopathological Findings in Patients with Follicular Dermatoses: All Skin Diseases Starts in the Hair Follicles as New Hypothesis

Research Article of American Journal of Clinical Research and Reviews Clinical and Histopathological Findings in Patients with Follicular Dermatoses: All Skin Diseases Starts in the Hair Follicles as New Hypothesis *Professor Khalifa E. Sharquie MD,PhD,FRCP Edin, *Professor Adil A. Noaimi MD, DDV, FICMS, **Dr. Rusul A. Flayih MD. *Department of Dermatology, College of Medicine, University of Baghdad. Iraqi and Arab Board for Dermatology and Venereology, Baghdad Teaching Hospital, Medical City, Baghdad, Iraq. ** Center of Dermatology; Baghdad Teaching Hospital; Medical City, Baghdad, Iraq. Background: Follicular dermatoses are group of skin diseases characterised by follicular lesions during the course of the disease. Objective: To gather all skin diseases where there is follicular lesions to be evaluated in order to reach the hypothesis that hair follicles are the most principal target area in the etiopathogenesis of these skin disorders. Patients and Methods: This is a descriptive, clinical and histopathological study that was carried out at the Department of Dermatology, Baghdad Teaching Hospital, Medical City, and Baghdad, Iraq during the period from November 2018 to August 2019. Sixty patients with different follicular dermatoses were enrolled and all socio- demographic data related to the disease was obtained from each patient, in addition to physical examination was performed for each patient. Biopsies were taken from 40 patients, for histopathological evaluation. Results: Sixty patient, were included in this study, 35 patients males and 25 patients females with male to female ratio 1.4:1. Their ages ranged from 1-80(30.2 ± 16.96) years. All patients had follicular lesions. The histopathological results showed: perifollicular lymphocytes, follicular invasion and degeneration, follicular plugging, fibrous tract remnant, perifollicular melanophages and absent melanin pigment in the epidermis of patients with vitiligo. Conclusion: The result of the present study showed that all skin diseases start in the hair follicles and might spread to involve the ...

Rising Incidence of Rubella among Patients With Febrile Rash Illness in a South Western State of Nigeria: a Ten Year Review

Research Article of American Journal of Clinical Research and Reviews Rising Incidence of Rubella among Patients With Febrile Rash Illness in a South Western State of Nigeria: a Ten Year Review KOLUDE, Olufunmilola1, EMMANUEL, Eyitayo E1, AJAYI, Paul1, ILESANMI, Mary1, IBIKUNLE, Funmi2, ONWU, Victor A2, ONYIBE, Rosemary3 1World Health Organization, Ekiti State Field Office, Ado Ekiti, Nigeria; 2State Ministry of Health, Ado Ekiti, Ekiti State Nigeria; 3World Health Organization, Southwest Zone Field office, Ibadan, Oyo State. Rubella infection is a differential diagnosis of febrile rash illnesses and its becoming more prevalent in countries yet to include Rubella containing vaccines into their routine immunization. It teratogenic effect in the first trimester of pregnancy is of public Health concern, hence this study aims to investigate the trend of Rubella infection in a Southwestern State of Nigeria over a ten-year period. A community based cross sectional retrospective study was conducted in all the 16 Local Government Areas and 177 wards of Ekiti state, using available records for Measles surveillance in the state. A review of the laboratory results of blood samples collected from all cases presenting with fever and maculopapular rashes in the state between 2010 and 2019 was done. Descriptive analysis of the data collected was done using SPSS version 22 and the results were presented in tables and charts. Level of statistical significance was set at p<0.05. A total of 4,634 cases of febrile rash illnesses were investigated during the period of study, and 2.5% (115) of them tested positive to Rubella IgM, out of which 53.9% of them were females. About 56% of all the cases of febrile rash illness in the period were below the age of 10years, 50.3% were females and 12.5% were within the reproductive age group. The trend of Rubella IgM positive cases revealed that 43% ...

Effectiveness and Safety of Apatinib Mesylate Tablet in the Treatment of Advanced Solid Tumors

Research Article of American Journal of Clinical Research and Reviews Effectiveness and Safety of Apatinib Mesylate Tablet in the Treatment of Advanced Solid Tumors LIU Gang, WANG Junfeng, GUAN Yiguo, WANG Fang, XU Yuanchun Tumour Hospital of Mudanjiang Angiogenesis is the most critical step in the development and progression of malignant tumors. Anti-tumor angiogenesis has become the most promising new strategy for tumor treatment. Rapidly growing tumor cells secrete a variety of vascular growth factors under hypoxia to stimulate tumor angiogenesis. One of the important growth factors is Vascular Endothelial Growth Factor (VEGF). Some small molecule compounds that inhibit VEGFR have been used to treat Tumors. In this study, we evaluated the effectiveness and safety of Apatinib Mesylate tablet in the treatment of advanced solid tumors. We found that Apatinib Mesylate tablet can treat advanced solid tumors. Keywords: Apatinib Mesylate Tablet, Treatment, Advanced Solid Tumors ...

Dr. Xiaoning Luo
Professor, Department of Otorhinolarygology-Head and Neck Surgery, Guangdong General Hospital, Guangzhou, China

Dr. N.S. NEKI
Professor & Head, Dept.of Medicine, Govt. Medical College, Amritsar, India

Dr. Prakash Prajapat
Assistant Professor, Department of Chemistry, Mehsana Urban Institute of Sciences, Ganpat University, Mehsana-384012, Gujarat, INDIA

Dr. Giuseppe Lanza
Consultant Neurologist and Clinical Researcher, Department of Neurology IC of the “Oasi” Institute for Research on Mental Retardation and Brain Aging (I.R.C.C.S.) in Troina (Italy)

Dr. Ayanabha Chakraborti
Senior Researcher, Department of Surgery, University of Alabama at Birmingham

Dr. Karol Szyluk
District Hospital of Orthopedics and Trauma Surgery

Dr. Yousif Mohamed Y. Abdallah
Professor (Assistant), Radiological Science and Medical Imaging Department, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia

Dr. Kabita Mishra
Senior Research Fellow (Homoeopathy), D.D.P.R.-Central Research Institute for Homoeopathy , (Ministry of A.Y.U.S.H., Government of India)

Dr. Dennis J. Mazur
Senior Scholar, Center for Ethics in Health Care, and Professor of Medicine, Oregon Health and Science University, Portland, Oregon USA

Dr. Nisar Haider Zaidi
MBBS, MS, MRCS (Glasgow), FICS, FACS. Department of surgery, King Abdulaziz University Hospital , POBox-80215 Jeddah 21589 , Saudi Arabia

Dr. Rajinder Pal Singh Bajwa
Niagara Falls Mem Med Center, Division of Infectious Diseases, 621 Tenth Street, Niagara Falls, NY 14301.

Dr. Pallavi Kamra
Pediatrician, Clinicas del Camino Real, Camarillo, CA

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1.Massimo Bolognesi. How to detect subtle ischemic heart disease in athletes or ex-athletes: a case report with a brief review. American Journal of Clinical Research and Reviews, 2017; 1:4. 

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly and send a notice to authors with the links of the paper.

Open Access

American Journal of Clinical Research and Reviews is a peer reviewed open access journal publishing research manuscripts, review articles, editorials, letters to the editor in Clinical Research and Reviews (Indexing details).

Peer Review

To ensure the quality of the publications, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

Rapid Publication

Time to first decision: within 2 days for initial decision without review, 18 days with review; Time to publication: Accepted articles will be published online within 2 days, and final corrected versions by authors will be accessible within 5 days.  More details....

Rapid Response Team

Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer your questions soon.

American Journal of Clinical Research and Reviews

Loading